Audet Juliette Berangere — SEC Form 4 filings

SEC reporting owner CIK 2000393. 5 Form 4 filings on record with FilingPulse; latest filed 2025-05-02.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-04-02 to 2025-05-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NewAmsterdam Pharma Co N.V. (NAMS)See Remarks51 leg · 1,104 sh · $17,3334

Form 4 filings — Audet Juliette Berangere

FiledFormIssuerReported transactionsSource
2025-05-024NewAmsterdam Pharma Co N.V. (NAMS)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-01-074NewAmsterdam Pharma Co N.V. (NAMS)Grant/award (A): 14,000EDGAR
2025-01-064NewAmsterdam Pharma Co N.V. (NAMS)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2024-09-304NewAmsterdam Pharma Co N.V. (NAMS)Purchase (P): 1,104 @ $15.70EDGAR
2024-04-024NewAmsterdam Pharma Co N.V. (NAMS)Grant/award (A): 250,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2000393 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →